Long Non-Coding RNAs Gene Variants as Molecular Markers for Diabetic Retinopathy Risk and Response to Anti-VEGF Therapy-Reference-Cited by-同舟云学术

Long Non-Coding RNAs Gene Variants as Molecular Markers for Diabetic Retinopathy Risk and Response to Anti-VEGF Therapy

Published:2021-08 Issue: Volume:Volume 14 Page:997-1014
ISSN:1178-7066
Container-title:Pharmacogenomics and Personalized Medicine
language:en
Short-container-title:PGPM

Author:

Mohammad Hala MF^ORCID,Abdelghany Ahmed A^ORCID,Al Ageeli Essam^ORCID,Kattan Shahad W^ORCID,Hassan Ranya,Toraih Eman A^ORCID,Fawzy Manal S^ORCID,Mokhtar Naglaa^ORCID

Publisher

Informa UK Limited

Subject

Pharmacology,Molecular Medicine

Reference48 articles.

1. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition

2. Pathogenic role of diabetes-induced PPAR- down-regulation in microvascular dysfunction

3. Analysis of long non-coding RNA expression profiles in high-glucose treated vascular endothelial cells

4. The role of epigenetics in the pathology of diabetic complications

5. Anti-inflammatory phytochemicals for the treatment of diabetes and its complications: Lessons learned and future promise

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decoding LncRNA in COPD: Unveiling Prognostic and Diagnostic Power and Their Driving Role in Lung Cancer Progression;International Journal of Molecular Sciences;2024-08-19

2. MIAT LncRNA: A multifunctional key player in non-oncological pathological conditions;Non-coding RNA Research;2024-06

3. Noncoding RNA Contribution to Aging and Lifespan;The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences;2024-02-23

4. lncRNA-MIAT rs9625066 polymorphism could be a potential biomarker for ischemic stroke;BMC Medical Genomics;2024-02-21

5. LncRNA as a regulator in the development of diabetic complications;Frontiers in Endocrinology;2024-02-08